Risk factors and comorbidities associated with magnesium deficiency in pregnant women and women with hormone-related conditions: analysis of a large real-world dataset

Table 1 Baseline characteristics and magnesium status of study participants

	Pregnant women (N = 983)	Women with hormone-related conditions
	Pregnant women (N = 983)	Hormonal contraception (n = 1562)	Premenstrual syndrome (n = 1549)	Climacteric syndrome^a,b (n = 1618)	HRT^b (n = 1555)	Osteoporosis (n = 1625)	Other^c (n = 1535)	Total (N = 9444)
Age, years
n/missing	983/0	1562/0	1549/0	1618/0	1555/0	1625/0	1535/0	9444/0
Median	28.0	30.0	29.0	51.	50.0	55.0	36.0	44.0
Q1; Q3	25.0; 32.0	25.0; 34.0	25.0; 35.0	48.0; 54.0	47.0; 54.0	51.0; 58.0	30.0; 42.0	31.0; 52.0
Min; Max	18; 52	18; 55	18; 56	29; 60	23; 60	19; 60	18; 59	18; 60
BMI, kg/m²
n/missing	983/0	1554/8	1540/9	1609/9	1546/9	1620/5	1532/3	9401/43
Median	23.10	22.10	22.40	27.20	26.30	27.10	24.20	25.00
Q1; Q3	20.90; 26.40	20.30; 24.60	20.30; 25.20	24.70; 30.50	24.00; 29.00	24.30; 30.50	21.80; 27.40	22.00; 28.30
Min; Max	15.9; 50.3	14.6; 48.5	15.6; 43.7	15.2; 63.4	13.8; 60.6	15.2; 51.8	14.8; 52.1	13.8; 63.4
Total blood serum magnesium, mmol/L
n/missing	983/0	1562/0	1549/0	1618/0	1555/0	1625/0	1535/0	9444/0
Mean (SD)	0.714 (0.125)	0.789 (0.197)	0.787 (0.193)	0.765 (0.198)	0.787 (0.219)	0.758 (0.199)	0.771 (0.180)	0.776 (0.198)
Median	0.700	0.780	0.790	0.750	0. 780	0.750	0.770	0.770
Q1; Q3	0.650; 0.780	0.680; 0.900	0.680; 0.890	0.650; 0.860	0.680; 0.890	0.640; 0.860	0.660; 0.890	0.660; 0.890
Min; Max	0.12; 1.92	0.09; 2.41	0.14; 2.50	0.20; 2.50	0.10; 4.08	0.20; 2.20	0.08; 2.50	0.08; 4.08

BMI Body mass index, HRT Hormone replacement therapy, Q Quartile
^aWomen with climacteric syndrome not receiving HRT
^bIncluding surgical menopause
^cWomen of reproductive age with other hormonal conditions: endometriosis, polycystic ovarian disease, uterine leiomyoma, dysmenorrhea, endometrial hyperplasia

ISSN: 1471-2393